Related Experiment Videos

Audit of thromboprophylaxis in women undergoing caesarean section

R Khan1, P Byrne

  • 1Department of Obstetrics and Gynaecology, Rotunda Hospital, Parnell Street, D.1, Royal College of Surgeons in Ireland.

Thromboembolism is a major cause of maternal mortality. Pregnancy is associated with an increased risk of thromboembolic diseases, with an even greater risk in women undergoing caesarean section. Since the introduction of the RCOG guidelines in 1995 on thromboprophylaxis for women undergoing caesarean section, there has been a significant reduction in the number of women dying from pulmonary embolism in the UK. The aims of our study was to conduct an audit cycle to assess our compliance with RCOG guidelines for thromboprophylaxis in women undergoing caesarean section to introduce changes in practice based on the observations of this audit, and to re-audit our practice to assess the effect of the changes. A retrospective audit of 100 women undergoing caesarean section was done in the Rotunda Hospital in June 2001. Changes in practice were introduced based on the findings of this audit. Obstetricians were asked to complete a checklist pre-operatively and to assign the patients a risk category-low, moderate or high. Prophylaxis was prescribed based on this risk assessment. Following the introduction of this change in practice, we re-audited 100 women delivered by caesarean section in June 2002. In the first audit, risk assessment was as follows: 20 low, 75 moderate and 5 high. Twenty-one of 75 (28%) of moderate risk patients in the first audit received appropriate prophylaxis. In the re-audit, risk assessment was as follows: 33 low, 66 moderate and 1 high. Following the introduction of new clinical practice, 45 of 66 (68%) of those in the moderate risk group received appropriate prophylaxis. All women in the low risk groups received appropriate prophylaxis in both audits. Our audit cycle of thromboprophylaxis in women undergoing caesarean section has demonstrated that the introduction of new clinical practice resulted in greater compliance with the RCOG guidelines, but further improvement could be achieved. These observations are discussed and recommendations are made to further improve compliance with RCOG guidelines.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...